ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Sexual Function Affected By Stem Cell Transplant

September 28, 2007

Health Organizations: Cancer Center, Organization Join to Promote Awareness Of Skin Cancer

April 11, 1997

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

NCI Cooperative Group, Cancer Center Trials Listed

August 31, 2007

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report

July 10, 1998